(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting’s included a session on biomarkers and salvage radiotherapy and discussion by Dr. Liat Hammer regarding results of a phase 1 trail of neoadjuvant stereotactic body radiotherapy prior to radical prostatectomy in locally advanced prostate cancer.
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting’s included a session on biomarkers and salvage radiotherapy and discussion by Dr. Alan Dal Pra regarding the performance of a genomic classifier within a phase 3 randomized trial of dose escalated salvage radiotherapy after radical prostatectomy. Genomic classifiers can independently prognosticate prostate cancer […]
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting included a joint ASTRO/SNMMI session on prostate cancer molecular imaging and radiotheranostics and a presentation by Dr. Joseph Caster discussing the emerging role of theranostic imaging agents for patients with biochemical failure after radical prostatectomy being considered for salvage external beam radiation. Dr. Caster […]
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting’s included a session on biomarkers and salvage radiotherapy and discussion by Dr. Ting Martin Ma regarding the prognostic significance of the risk of non-localized disease on PSMA/PET CT.
(UroToday.com) In an interactive session of the American Society for Radiation Oncology (ASTRO) Annual Congress focussing on the management of patients with Intermediate Risk Prostate Cancer from initial consultation through treatment to follow-up, Dr. Kollmeier presented on the role of hypofractionation.
(UroToday.com) In an interactive session of the American Society for Radiation Oncology (ASTRO) Annual Congress focussing on the management of patients with Intermediate Risk Prostate Cancer from initial consultation through treatment to follow-up, Dr. Michael Wan-Tien Chao presented on the role of rectal spacers.
(UroToday.com) In an interactive session of the American Society for Radiation Oncology (ASTRO) Annual Congress focussing on the management of patients with Intermediate Risk Prostate Cancer from initial consultation through treatment to follow-up, Dr. Neil Desai presented on the conundrum that is intermediate prostate cancer: while we have a wealth of choices, this can make treatment […]
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Hybrid Annual Meeting’s included a session on biomarkers and salvage radiotherapy and a discussant presentation of five presentations in this session by Dr. Brian Baumann. With regards to organizing these five presentations into clinical context, Dr. Baumann provided the following summary outline: In radical prostatectomy patients: […]
(UroToday.com) The 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting’s included a session on biomarkers and salvage radiotherapy and discussion by Dr. Paul Nguyen regarding the validation of a 22-gene genomic classifier in the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials.
(UroToday.com) In an educational session of the American Society for Radiation Oncology (ASTRO) Annual Congress focussing on Multidisciplinary Management of Very High Risk Prostate Cancer, Dr. Sarah Psutka presented on the role of surgery for these patients.
